Nateglinide

FDA Approved: * September 9, 2009
Pharm Company: * PAR PHARM
Category: Diabetes

Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto, a Japanese company and sold by the Swiss pharmaceutical company Novartis. Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs. Contents 1 Pharmacology 2 Contraindications 3 Comparisons with other drugs for type 2 diabetes 4 Dosage 5 See also 6 References 7 External links Pharmacology Nateglinide lowers blood glucose by stimulating the re... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
4 Discussions

Dosage List

Nateglinide P;984
Nateglinide 60 mg Oral Tablet
NDC: 68084-458
Labeler:
American Health Packaging
Nateglinide P;985
Nateglinide 120 mg Oral Tablet
NDC: 68084-459
Labeler:
American Health Packaging
Nateglinide P;984
Nateglinide 60 mg Oral Tablet
NDC: 0615-7585
Labeler:
Ncs Healthcare of Ky, Inc Dba Vangard Labs
Nateglinide P;985
Nateglinide 120 mg Oral Tablet
NDC: 0615-7586
Labeler:
Ncs Healthcare of Ky, Inc Dba Vangard Labs
Nateglinide P;984
Nateglinide 60 mg Oral Tablet, Coated
NDC: 42291-636
Labeler:
Avkare, Inc.
Nateglinide P;985
Nateglinide 120 mg Oral Tablet, Coated
NDC: 42291-637
Labeler:
Avkare, Inc.
Nateglinide P;984
Nateglinide 60 mg Oral Tablet
NDC: 49884-984
Labeler:
Par Pharmaceutical Inc.
Nateglinide P;985
Nateglinide 120 mg Oral Tablet
NDC: 49884-985
Labeler:
Par Pharmaceutical Inc.
Nateglinide P;985
Nateglinide 120 mg Oral Tablet
NDC: 54868-6255
Labeler:
Physicians Total Care, Inc.
Nateglinide P;984
Nateglinide 60 mg Oral Tablet, Coated
NDC: 60429-434
Labeler:
Golden State Medical Supply, Inc.
More Results

Related Brands

Drugs with the same active ingredients